1. What It Is (Mechanism of Action)

Melanotan II is a synthetic cyclic heptapeptide analog of alpha-melanocyte-stimulating hormone ($alpha$-MSH). It acts as a potent non-selective agonist across melanocortin receptors MC1R, MC3R, MC4R, and MC5R.

2. Clinical Indications Under Study

Originally investigated for photoprotection and tanning; prompted subsequent research into the selective MC4R derivative bremelanotide (PT-141) for sexual dysfunction.

3. FDA Approval & Regulatory Status

Status:Banned / Illegal for Human Use (FDA Blacklist & Warning Letters)

Banned / Illegal for Human Use (FDA Blacklist & Warning Letters)

4. Human Clinical Evidence Summary

Melanotan II was abandoned in formal clinical trials due to severe systemic toxicity. Clinical literature consists almost entirely of adverse emergency room case reports.

5. Known Risks, Side Effects & Boxed Warnings

Severe systemic risks: systemic hypertension, priapism, nausea, facial flushing, rapid darkening of atypical nevi (dysplastic moles), rhabdomyolysis, renal infarction, and potential acceleration of malignant melanoma. Subject to multiple FDA public health warnings and seizure actions.

7. Why Gray-Market "Research Chemical" Versions Are Risky

Extreme risk profile. Nasal sprays and injectable vials sold online are notoriously adulterated, non-sterile, and associated with life-threatening toxicities.
The Peptides Agora Briefing

Get Breaking Melanotan II Clinical Trial Alerts

Receive verified FDA dockets, Phase 3 readouts, and independent HPLC lab audits directly from our medical journalism desk.

Clinical trials · FDA decisions · Laboratory testing

Weekly. No vendor sponsorship. Unsubscribe anytime.

8. Questions to Ask a Licensed Clinician

If you are discussing this compound with your doctor or healthcare provider, consider bringing these evidence-based questions:

  • Q1: What are the documented dermatological and oncogenic risks associated with non-selective melanocortin stimulation?
  • Q2: How can I safely monitor preexisting moles and dysplastic nevi after exposure to unregulated tanning peptides?

9. Primary Peer-Reviewed Sources & Citations

  • [1] FDA Consumer Alert: FDA warns consumers against the use of unapproved, dangerous tanning products containing Melanotan. PubMed / Source →
  • [2] Nelson ME, et al. Melanotan II: A cause of atypical melanocytic nevi and systemic toxicity. Dermatol Online J. 2012;18(11):1. PubMed / Source →

Related Research

Assess the evidenceCheck FDA statusReview legal context
Medical & Editorial Disclaimer:This educational monograph is for scientific reference, academic training, and regulatory analysis only. Peptides Agora does not provide medical advice or endorse the non-prescribed use of unapproved peptides. Always consult a licensed medical clinician regarding diagnosis and therapeutic treatments.